TrialBritish journal of clinical pharmacology2026

Main factors associated with variability in the assessment of the objective response rate. A re-analysis of the PHEREXA phase 3 clinical trial.

Gennaro Daniele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.